Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of RIGL by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−343,897−100.0%Sold outHolders
Q1 2026343,897$9.30M<0.1%+55,628+19.3%AddedHolders
Q4 2025288,269$12.3M<0.1%−72,697−20.1%ReducedHolders
Q3 2025360,966$10.2M<0.1%+189,542+110.6%AddedHolders
Q2 2025171,424$3.21M<0.1%+16,807+10.9%AddedHolders
Q1 2025154,617$2.78M<0.1%+36,660+31.1%AddedHolders
Q4 2024117,957$1.98M<0.1%+117,957NewHolders
Q3 20240$00.0%−17,667−100.0%Sold outHolders
Q2 202417,667$145.2K<0.1%+8,596+94.8%AddedConverted for a 1-for-10 splitHolders
Q1 202490,708$134.2K<0.1%+90,708NewHolders
Q4 20230$00.0%−124,331−100.0%Sold outHolders
Q3 2023124,331$134.3K<0.1%−26,481−17.6%ReducedHolders
Q2 2023150,812$194.5K<0.1%−322,554−68.1%ReducedHolders
Q1 2023473,366$624.8K<0.1%+473,366NewHolders
Q4 20220$00.0%−576,606−100.0%Sold outHolders
Q3 2022576,606$680.0K<0.1%+576,606NewHolders
Q2 20220$00.0%−112,005−100.0%Sold outHolders
Q1 2022112,005$335.0K<0.1%+9,189+8.9%AddedHolders
Q4 2021102,816$272.0K<0.1%−8,633−7.7%ReducedHolders
Q3 2021111,449$405.0K<0.1%+92,076+475.3%AddedHolders
Q2 202119,373$84.0K<0.1%−71,812−78.8%ReducedHolders
Q1 202191,185$312.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.